AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
5.59
-0.25 (-4.28%)
At close: Oct 17, 2025, 3:59 PM
5.63
0.72%
After-hours: Oct 17, 2025, 05:11 PM EDT
AbCellera Biologics Operating Metrics
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Discovery Partners | - | - | - | - | - | 46 | 42 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Number of Discovery Partners Growth | - | - | - | - | - | +9.52% | +2.44% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - |
| Programs Under Contract | - | - | - | - | - | 203 | 182 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Programs Under Contract Growth | - | - | - | - | - | +11.54% | +2.82% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - |
| Partnered Program Starts | - | - | - | - | - | 404 | 392 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Partnered Program Starts Growth | - | - | - | - | - | +3.06% | +4.81% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - |
| Number of Molecules in the Clinic | 16 | 16 | 14 | 14 | 13 | 13 | 10 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - |
| Number of Molecules in the Clinic Growth | 0.00% | +14.29% | 0.00% | +7.69% | 0.00% | +30.00% | +11.11% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - | - |
Revenue by Segment
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Licensing | 1.04M | 1.05M | 953K | 921K | 777K | 969K | 948K | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - | - | - | - |
| Licensing Growth | -1.24% | +10.07% | +3.47% | +18.53% | -19.81% | +2.22% | +3.49% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - | - | - | - | - |
| Royalty | - | - | - | - | - | - | - | - | - | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - | - | - |
| Royalty Growth | - | - | - | - | - | - | - | - | - | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - | - | - | - |
| Research Fees | 20.58M | 26.28M | 30.26M | 30.38M | 34.76M | 35.56M | 38.24M | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Research Fees Growth | -21.71% | -13.14% | -0.41% | -12.59% | -2.24% | -7.01% | -2.78% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - |
| Milestone Payments | - | - | - | 3.5M | - | 2.4M | - | - | Upgrade | Upgrade | Upgrade | - | - | - | - | Upgrade | Upgrade | - |
| Milestone Payments Growth | - | - | - | - | - | - | - | - | Upgrade | Upgrade | - | - | - | - | - | Upgrade | - | - |